(Q40607448)

22 September 2017

Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs (English)

1 reference

Human T-lymphotropic virus 1

22 September 2017

0 references

3

Stephen H Hughes

1 reference

22 September 2017

Gerald L Princler

1

1 reference

22 September 2017

John G Julias

series ordinal

2

1 reference

22 September 2017

David Derse

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

22 September 2017

1 reference

22 September 2017

317

1 reference

22 September 2017

1

1 reference

22 September 2017

136-145

1 reference

Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Reexamination of the coding potential of the HTLV-1 pX region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT-2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

In vivo infection of human T-cell leukemia virus type I in non-T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Finding signals that regulate alternative splicing in the post-genomic era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Human T-lymphotropic virus type I infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

In vivo production of Rof and Tof proteins of HTLV type 1: evidence from cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Human papillomavirus life cycle: active and latent phases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

HTLV-1 Tax: regulation of gene expression and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

inferred from DOI database lookup

7 January 2021

based on heuristic

The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

inferred from DOI database lookup

7 January 2021

based on heuristic

The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2003.09.010

1 reference

22 September 2017

1 reference